Northwire Canada EditionTuesday, August 25, 2026
Northwire
GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0%
Production / Operations Routine +

Cannabix Expands BreathLogix Alcohol Screening Technology into Mining, Municipal and Aviation Sectors in Australia

Cannabix Expands Australian Footprint as MBT Certification Progresses Amidst Volatility

Executive Summary
  • Cannabix Technologies Inc. announced the deployment of its BreathLogix alcohol screening technology into mining, municipal, and aviation sectors in Australia on May 29, 2026.
  • Deployment is executed under an exclusive distribution partnership with Breathalyser Sales & Service Pty Ltd.
  • The automated system enables workplace safety compliance through pre-shift testing, identity verification, and integration into access control workflows without dedicated administration personnel.
  • Key features include contactless and straw modes, user photograph capture for identity verification, precise Blood Alcohol Content (BAC/BrAC) readings, and real-time SMS/email alerts to supervisors.
  • The system integrates with cloud-based BreathLogix Connect platform for secure data logging and reporting across multiple locations.
Material Impact
  • This news represents an execution update on the December 30, 2025 announcement regarding the first international distributor order with Breathalyser Sales & Service Pty Ltd.
  • The specific sector expansion (Mining, Municipal, Aviation) confirms commercial traction but does not disclose contract values or revenue figures.
  • Given the stock price decline from $0.75 on May 25 to $0.65 on May 28 prior to this release, the news serves as a stabilizing factor rather than a catalyst for significant upside without financial proof of scale.
  • The Marijuana Breath Test (MBT) certification milestones achieved in May 2026 (UL/CSA) complement this alcohol screening expansion, diversifying revenue streams but maintaining reliance on partnership execution.
  • No new capital raise or strategic investor entry is announced; dilution risk remains tied to previous financing structures.
BLO · Price
Company Overview
  • Company: Cannabix Technologies Inc., a technology company focused on breath-based detection solutions for alcohol and cannabis impairment.
  • Flagship Projects:
    • BreathLogix: Alcohol screening system targeting safety-critical industries (Mining, Maritime, Aviation). Features unmanned access control integration.
    • Marijuana Breath Test (MBT): Portable system detecting recent delta-9 THC use in breath within a 4-hour window using LC-MS analysis.
  • Development Status:
    • MBT has achieved UL/CSA certifications and FCC compliance. Peer-reviewed validation study published in Journal of Analytical Toxicology (March 2026).
    • BreathLogix has secured NHTSA approval for the Workplace Series device and USPTO patent grant for contactless breath analysis (October 2025).
Read the original news release →

More from Cannabix Technologies Inc.